drugset / Trial / NCT00246389

An Effectiveness and Safety Study of Cyclobenzaprine HCl Alone or in Combination With Ibuprofen for Acute Back or Neck Muscle Pain With Muscle Spasm

NCT00246389 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effectiveness and safety of cyclobenzaprine HCl 5 mg (muscle spasm medication) taken three times a day, alone or in combination with ibuprofen 400 mg or 800 mg (pain relief medication) taken three times a day, for the treatment of back or neck muscle pain with muscle spasm.

Timeline

Start
—
Primary completion
—
Completion
2004-07

Outcome

Missed primary endpoint

paper combination therapy with cyclobenzaprine 5 mg TID plus ibuprofen was not superior to cyclobenzaprine 5 mg TID alone PMID 16197668 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject cyclobenzaprine Unknown 5 mg Oral

Indications

No indication recorded.